CHEMICALS · NSE/BSE: ROSSARI

Rossari Biotech Limited Earnings Summary — Q2 FY2027

Sentiment: Positive

AI-generated summary

Generated 2026-10-22

Business Intelligence Report

Rossari Biotech Limited Q2 FY2027 results: Profit up +5.5% YoY; revenue grew +19.0% YoY; OPM 12.5%.

Quarterly Business Intelligence

Q2 FY2027

Financials from Financial Intelligence · data as of 2026-09-30

Revenue

₹698 Cr

QoQ +0.1%YoY +19.0%

Net Profit

₹39 Cr

QoQ +10.9%YoY +5.5%

Operating Profit

₹87 Cr

QoQ +7.9%YoY +20.9%

Operating Margin

12.5%

QoQ +91 bpsYoY +20 bps

AI Quarterly Scorecard™

/ 100

Strong

Revenue Momentum83

Profit Growth69

Margin Expansion46

Growth Consistency77

Operating Efficiency67

Financial Stability78

Computed deterministically from the last 10 reported quarters.

Quarterly Business Momentum

Revenue & Growth

Revenue has increased for 4 consecutive quarters.
Revenue of ₹698 Cr is 19.0% higher year-on-year.
Revenue has compounded at 17.0% annualised over the last 10 quarters.
Revenue is at its highest level in 10 quarters.

Profitability

Net profit of ₹39 Cr is 5.5% above the same quarter last year.
Profit growth is trailing revenue growth this quarter.
Net profit has compounded at 5.0% annualised across the period.

Margins

Operating margin stands at 12.5% in Q2 FY2027.
Operating margin expanded by 20 bps year-on-year.
Over the last two years operating margin has contracted by 76 bps.
PBT margin is 7.1%.

Operating Efficiency

Expense growth of 18.7% remained below revenue growth of 19.0%.
Operating profit of ₹87 Cr is 20.9% higher year-on-year.
Operating leverage continues to improve.

Overall Momentum

6 of the last 6 measured quarters delivered year-on-year revenue growth.
Overall quarterly business momentum scores 70/100 (Strong) on the latest 10 quarters.
Business momentum remains positive heading into the next quarter.

Quarterly Financials

Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %

Metric	Trend	Latest Q2 FY2027	Q1 FY2027	Q4 FY2026	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025
Revenue	Improving	698	697	685	582	586	544	580	513	498	490
Expenses	Improving	611	617	608	513	514	476	510	448	432	425
Operating Profit	Improving	87	81	77	69	72	68	69	65	66	65
Operating Margin	Stable	12.5%	11.6%	11.3%	11.8%	12.3%	12.5%	12.0%	12.6%	13.2%	13.3%
Other Income	Volatile	1	4	20	1	2	2	2	1	1	1
Interest	Improving	9	11	9	8	6	6	6	5	4	4
Depreciation	Improving	30	26	24	20	18	18	18	18	15	15
Profit Before Tax	Stable	49	48	64	43	50	46	48	42	48	47
Tax	Accelerating	10	13	18	10	13	13	13	11	13	12
Net Profit	Stable	39	35	46	33	37	34	34	32	35	35
Net Margin	Stable	5.6%	5.0%	6.7%	5.6%	6.3%	6.2%	5.9%	6.2%	7.1%	7.1%

Source: Financial Intelligence (Structured Quarterly Data)•Latest Quarter: Q2 FY2027•Figures in ₹ Crore • Margins in %•Automatically updated from Financial Intelligence · 2026-09-30

Key Takeaways

Profit up +5.5% YoY; revenue grew +19.0% YoY; OPM 12.5%.

Official Quarterly Documents

Earnings Press Release

Official quarterly earnings release published by the company.

Press Release not available.

Earnings Call Transcript

Management discussion and analyst Q&A.

This summary is AI-generated from Rossari Biotech Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.